Researchers from North Carolina State University, the University of North Carolina at Chapel Hill and First Affiliated Hospital of Zhengzhou University have developed a synthetic version of a cardiac stem cell.
You are here
Coverage of the latest news and updates from ongoing clinical trials from various sources.
Cincinnati Children's researchers report a new mechanism that controls blood cell function and several possible molecular targets for treating myelodysplasia syndromes (MDS), a group of pre-malignant disorders in which bone marrow does not produce enough healthy blood cells.
Male hypogonadism is a condition that diminishes testosterone levels in approximately 30 percent of older men, but currently available therapies can produce serious side effects.
Scientists at the Salk Institute have studied a 3D "mini-brain" grown from human stem cells and found it to be structurally and functionally more similar to real brains than the 2D models in widespread use.
In a first-in-children randomized clinical study, medical researchers at the University of Maryland School of Medicine (UM SOM) and the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami Miller School of Medicine have begun testing to see whether adult stem cells derived from
Neural stem cells have been found in epileptic brain tissue — outside the regions of the brain where they normally reside.
Blood-forming stem cells are able to count and store memories of the number of times that they divide, findings that could have major implications for disease research, scientists at the Icahn School of Medicine at Mount Sinai have found.
A "living bandage" made from stem cells, which could revolutionize the treatment and prognosis of a common sporting knee injury, has been tested in humans for the first time by scientists at the Universities of Liverpool and Bristol.
Scientists from the McEwen Centre for Regenerative Medicine, University Health Network, have developed the first functional pacemaker cells from human stem cells, paving the way for alternate, biological pacemaker therapy.
Ever since researchers connected the shortening of telomeres — the protective structures on the ends of chromosomes — to aging and disease, the race has been on to understand the factors that govern telomere length.